Alkem Laboratories Ltd

Growth Ratio Summary

Growth Score : 10.00

Alkem Laboratories demonstrates outstanding growth across all key metrics. Revenue, operating profit, EPS, assets, and net income are all growing at high rates. This reflects strong market positioning, effective management strategies, and a robust ability to capitalize on opportunities. The company's consistent growth underscores its financial health and potential for future success.

Financial Ratio Summary

Financial Score : 8.40

Alkem Laboratories demonstrates a strong financial performance with high adjusted EPS, cash EPS, and book value per share. The company's dividend per share is also robust, reflecting its commitment to returning value to shareholders. However, the high capital expenditures indicate significant investments, which need to be carefully managed to ensure they yield positive returns. Overall, the company exhibits solid financial health with areas needing focused attention.

Profitability Ratio Summary

Profitability Score : 10.00

Alkem Laboratories exhibits outstanding profitability across all key metrics. High gross profit margins, ROCE, ROE, ROA, operating margins, and net margins demonstrate efficient operations and strong financial performance. The company effectively manages its costs and generates substantial profits from its revenue. This robust profitability underscores the company's financial health and competitive advantage.

Efficiency Ratio Summary

Efficiency Score : 3.67

Alkem Laboratories faces significant challenges in its efficiency. All turnover ratios are low, suggesting potential issues with asset utilization and operational processes. The company needs to improve how it uses its assets to generate revenue. The extended days sales in inventory and receivable days indicate slow inventory turnover and collections, which could tie up working capital and affect cash flow. Boosting operational efficiency will be crucial for enhancing overall performance.

Coverage Ratio Summary

Coverage Score : 9.20

Alkem Laboratories exhibits strong coverage ratios, indicating a robust ability to meet its interest and dividend obligations. The company comfortably covers its interest expenses with its earnings, and its equity dividend coverage is also solid. This reflects prudent financial management and a low risk of financial distress. The company's financial stability is enhanced by its ability to service its debts and dividends effectively.

Solvency Ratio Summary

Solvency Score : 10.00

Alkem Laboratories exhibits excellent solvency, indicating a strong and stable financial structure. The company maintains very low levels of debt relative to equity and assets, reflecting a conservative approach to financial leverage. This strong equity base provides a solid foundation for future growth and resilience against economic downturns. The company's financial risk is minimized due to its robust solvency position, enhancing its long-term sustainability.

Liquidity Ratio Summary

Liquidity Score : 7.46

Alkem Laboratories demonstrates a mixed liquidity profile. While the quick ratio indicates a strong ability to meet short-term obligations with highly liquid assets, the current ratio suggests there is room for improvement in managing current assets and liabilities. The cash ratio, being average, points to moderate cash reserves. The operating cash flow ratio is weak, indicating challenges in generating sufficient cash from operations to cover current liabilities. Overall, the company maintains high liquidity but optimizing cash flow from its operations will be beneficial.